Abstract
Reactive species provoke amplification of inflammatory response in the airways and lung parenchyma causing inhibition of mitochondrial respiration, and lipid, protein, and DNA damage causing oxidative stress. Long-term persistence of oxidative stress may contribute to progressive deterioration of pulmonary functions leading to respiratory failure. Recent reports, suggesting protein nitration as dynamic and reversible (denitration) mechanism, open new horizons in the treatment of chronic respiratory disease affected by deleterious action of nitrosative stress. Reduced antioxidants in the body overwhelm the system with oxidants and promote cellular oxidative stress. Different species of ROS activate various transcription factors altering signaling pathways, and lead to divergent cellular response.
Therapeutic interventions which increase endogenous lung antioxidants, or with administration of exogenous antioxidants which reduce effects of environmental exposure to oxidants may prove to be beneficial as adjunct therapies in respiratory disorders. Hundreds of antioxidant supplements are readily available in the market which require regulation for efficacy and side effects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Commoner B, Townsend J, Pake GE (1954) Free radicals in biological materials. Nature 174:689–691
Harman D (1956) Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298–300
Harman D (1981) The aging process. Proc Natl Acad Sci U S A 78:7124–7128
Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47–95
Halliwell B (1994) Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 344(8924):721–724
Dupont GP, Huecksteadt TP (1992) Regulation of xanthine dehydrogenase and xanthine oxidase activity and gene expression in cultured rat pulmonary endothelial cells. J Clin Invest 89(1):197–202
Forman H, Fukuto JM, Miller T et al (2008) The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477(2):183–195
Fridovich I (1987) The biology of oxygen radicals. Science 201:875–880
Gielis JF, Lin JY, Wingler K et al (2011) Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radic Biol Med 50(7):765–776
Crapo JD (2003) Oxidative stress as an initiator of cytokine release and cell damage. Eur Respir J 22(suppl 44):4s–6s
Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84
Jain M, Stephaine R, Elena A et al (2013) Mitochondrial reactive oxygen species regulate TGF-beta signaling. J Biol Chem 288(2):770–777
Tabima DM, Shiella F, Mark T et al (2012) Reactive oxygen and nitrogen species in pulmonary hypertension. Free Radic Biol Med 52(9):1970–1986
Miyano KS, Takeya R et al (2005) Molecular composition and regulation of the Nox family NAD(P)H oxidases. Biochem Biophys Res Commun 338(1):677–686
Boveris T (1980) Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J 191(2):421–427
Crosswhite P, Sun Z (2010) Nitric oxide, oxidative stress and inflammation in pulmonary arterial hypertension. J Hypertens 28(2):201–212
Nishino T, Okamoto K, Eger BT et al (2008) Mammalian xanthine oxidoreductase—mechanism of transition from xanthine dehydrogenase to xanthine oxidase. FEBS J 275(13):3278–3289
Harrison R (2004) Physiological roles of xanthine oxidoreductase. Drug Metab Rev 36(2):363–375
Takano Y, Hase-Aoki K, Horiuchi H et al (2005) Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase. Life Sci 76(16):1835–1847
Palmer RM, Rees DD, Ashton DS et al (1980) L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun 153(3):1251–1256
Furchgott RF, Zawadzki JV (1980) The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373–376
Culotta E, Koshland DE Jr (1992) NO news is good news. Science 258(5090):1862–1864
Furchgott RF, Jothianandan D (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52–61
Ignarro LJ (1990) Biosynthesis and metabolism of endothelium-derived nitric oxide. Annu Rev Pharmacol Toxicol 30:535–560
Arnold WP, Mittal CK, Katsuki S, Murad F (1977) Nitric oxide activates guanylatecyclase and increases guanosine 3’:5’-cyclic monophosphate levels in various tissue preparations. Proc Natl Acad Sci U S A 74:83203–83207
White KA, Marletta MA (1992) Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry 31(29):6627–6631
McMillan K, Bredt DS, Hirsch DJ et al (1992) Cloned, expressed rat cerebellar nitric oxide synthase contains stoichiometric amounts of heme, which binds carbon monoxide. Proc Natl Acad Sci U S A 89(23):11141–11145
Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH (1991) Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 351(6329):714–718
Marsden S, Chappert KT, Chen HS et al (1992) Molecular cloning and characterization of human endothelial nitric oxide synthase. FEBS Lett 307:287–293
Bredt DS (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87(2):682–685
Long CJ (1985) The release of endothelium-derived relaxant factor is calcium dependent. Blood Vessels 22:205–208
Busse R (1990) Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS J 265(1–2):133–136
Radomski MW, Palmer RM, Moncada S (1987) The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol 92(3):639–646
Stamler JS, Singel DJ, Loscalzo J (1992) Biochemistry of nitric oxide and its redox-activated forms. Science 258:1898–1902
Ignarro LJ, Kadowitz PJ (1985) The pharmacological and physiological role of cyclic GMP in vascular smooth muscle relaxation. Annu Rev Pharmacol Toxicol 25:171–191
Michel T, Li GK, Busconi L (1993) Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 90:6252–6256
Brüne B, Lapetina EG (1989) Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem 264:8455–8458
Carr AC et al (2000) Oxidation of ldl by myeloperoxidase and reactive nitrogen species reaction pathways and antioxidant protection. Arterioscler Thromb Vasc Biol 20:1716–1723
Li JX (1999) Antioxidants and oxidative stress in exercise. Exp Biol Med 222(3):283–292
Datta K, Sinha S, Chattopadhyay P (2000) Reactive oxygen species in health and disease. Natl Med J India 13(6):304–310
Faraci FM, Didion SP (2004) Vascular protection superoxide dismutase isoforms in the vessel wall. Arterioscler Thromb Vasc Biol 24:1367–1373
Schafer FQ, Buettner GR (2001) Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 30(11):1191–1336
Arrigo AP (1999) Gene expression and the thiol redox state. Free Radic Biol Med 27(9–10):915–1134
Trachootham D, Lu W, Ogasawara MA (2008) Redox regulation of cell survival. Antioxid Redox Signal 10(8):1343–1374
Lander HM (1997) An essential role for free radicals and derived species in signal transduction. FASEB J 11:118–124
Kabe Y et al (2005) Redox regulation of NF-κB activation: distinct redox regulation between the cytoplasm and the nucleus. Antioxid Redox Signal 7(3–4):395–403
Pantano C, Reynaert NL, van der Vliet A et al (2006) Redox-sensitive kinases of the nuclear factor-kappa B signaling pathway. Antioxid Redox Signal 8:1791–1806
Shaulian E (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131–E136
Forman HJ, Fukuto M, Tom M et al (2008) The chemistry of cell signaling by reactive oxygen and nitrogen species and 4-hydroxynonenal. Arch Biochem Biophys 477(2):183–195
Schaur RJ (2003) Basic aspects of the biochemical reactivity of 4-hydroxynonenal. Mol Aspects Med 24(4–5):149–159
Turrens JF (2003) Mitochondrial formation of reactive oxygen species. J Physiol 552:335–344
Irrcher I, Ljubicic V, Hood DA (2009) Interactions between ROS and AMP kinase activity in the regulation of PGC-1α transcription in skeletal muscle cells. Am J Physiol Cell Physiol 296(1):C116–C123
Colombo SL, Moncada S (2009) AMPKalpha1 regulates the antioxidant status of vascular endothelial cells. Biochem J 421(2):163–169
Torres M (2003) Mitogen-activated protein kinase pathways in redox signaling. Front Biosci 8:d369–d391
Knebel A, Rahmsdorf HJ, Ullrich A et al (1996) Dephosphorylation of receptor tyrosine kinases as target of regulation by radiation, oxidants or alkylating agents. EMBO J 15:5314–5325
Yu C, Friday BB, Lai JP et al (2007) Abrogation of MAPK and Akt signaling by AEE788 synergistically potentiates histone deacetylase inhibitor-induced apoptosis through reactive oxygen species generation. Clin Cancer Res 13(4):1140–1148
Warren JR, Zee R et al (2001) Cellular thiols and reactive oxygen species in drug-induced apoptosis. J Pharmacol Exp Ther 296(1):1–6
Salmeen A, Barford D (2005) Functions and mechanisms of redox regulation of cysteine-based phosphatases. Antioxid Redox Signal 7(5–6):560–577
Pelicano H, Xu RH, Du M, Feng L et al (2006) Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 175(6):913–923
Poppek D, Grune T (2006) Proteasomal defense of oxidative protein modifications. Antioxid Redox Signal 8(1–2):173–184
Toledano MB (2009) The guardian recruits cops: the p53-p21 axis delegates prosurvival duties to the Keap1-Nrf2 stress pathway. Mol Cell 34(6):637–639
Thimmulappa R, Kim H, Srisuma S et al (2002) Identification of Nrf2-regulated genes induced by the chemopreventive agent sulforaphane by oligonucleotide microarray. Cancer Res 62(18):5196–5203
Stępkowski TM, Kruszewski MK (2011) Molecular cross-talk between the NRF2/KEAP1 signaling pathway, autophagy, and apoptosis. Free Radic Biol Med 50(9):1186–1195
Szabo C (2003) Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 140–141:105–112
Marotta F, Naito Y, Jain S et al (2012) Is there a potential application of a fermented nutraceutical in acute respiratory illnesses? An in-vivo placebo-controlled, cross-over clinical study in different age groups of healthy subjects. J Biol Regul Homeost Agents 26(2):285–294
Fu P, Birukova AA, Xing J et al (2009) Amifostine reduces lung vascular permeability via suppression of inflammatory signaling. Eur Respir J 33:612–624
Fu P, Murley JS, Grdina DJ et al (2011) Induction of cellular antioxidant defense by amifostine improves ventilator-induced lung injury. Crit Care Med 39(12):2711–2721
Moretti M (2007) Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease. Expert Rev Respir Med 1(3):307–316
Martin GS, Robert J, Arthur P et al (2002) Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 30:2175–2182
Biswas SK, Rahman I (2009) Environmental toxicity, redox signaling and lung inflammation: the role of glutathione. Mol Aspects Med 30(1–2):60–76
Radomska-Leśniewska DM (2012) N-acetylcysteine as an anti-oxidant and anti-inflammatory drug and its some clinical applications. Cent Eur J Immunol 37(1):57–66
Korkmaz A, Reiter RJ, Topal T et al (2009) Melatonin: an established antioxidant worthy of use in clinical trials. Mol Med 15(1–2):43–50
Xie XH, Zang N, Li SM et al (2012) Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and downregulates TRIF expression in airway epithelial cells. Inflammation 35(4):1392–1401
Lyzogub VH, Altunina NV, Bondarchuk OM (2011) Application of alpha-lipoic acid in clinical practice. Lik Sprava 7–8:20–28
Hoffer LJ, Tamayo C, Richardson MA (2000) Vitamin C as cancer therapy: an overview. J Orthomol Med 15(4)
Tao L, Jiao X, Gao E et al (2006) Nitrative inactivation of thioredoxin-1 and its role in postischemic myocardial apoptosis. Circulation 114(13):1395–1402
Edes K, Cassidy P, Shami PJ et al (2010) JS-K, a nitric oxide prodrug, has enhanced cytotoxicity in colon cancer cells with knockdown of Thioredoxin Reductase 1. PLoS One 5(1):e8786
Vasu VT, de Cruz SJ, Houghton JS et al (2011) Evaluation of thiol-based antioxidant therapeutics in cystic fibrosis sputum: focus on myeloperoxidase. Free Radic Res 45(2):165–176
Schünemann HJ, Freudenheim JL, Grant BJ (2001) Epidemiologic evidence linking antioxidant vitamins to pulmonary function and airway obstruction. Epidemiol Rev 23(2):248–267
Smit HA (2001) Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? Respir Res 2:261–264
Sun B (2012) Inhaled nitric oxide and neonatal brain damage: experimental and clinical evidences. J Matern Fetal Neonatal Med 25(suppl 1):51–54
Fan E, VillarJ SJS (2013) Novel approaches to minimize ventilator-induced lung injury. BMC Med 11:85
Day BJ (2005) Glutathione: a radical treatment for cystic fibrosis lung disease? Chest 127(1):12–14
Hudson VM (2004) New insights into the pathogenesis of cystic fibrosis: pivotal role of glutathione system dysfunction and implications for therapy. Treat Respir Med 3(6):353–363
Afshari A, Brok J, Moller AM et al (2011) Inhaled nitric oxide for acute respiratory distress syndrome and acute lung injury in adults and children: a systematic review with meta-analysis and trial sequential analysis. Anesth Analg 112(6):1411–1421
Cortes GA, Marini JJ (2012) Update: adjuncts to mechanical ventilation. Curr Opin Anaesthesiol 25(2):156–163
Dushianthan A (2011) Acute respiratory distress syndrome and acute lung injury. Postgrad Med J 87(1031):612–622
Donohue PK, Maureen M, Wilson RF et al (2011) Inhaled nitric oxide in preterm infants: a systematic review. Pediatrics 127(2):e414–e422
Al Hajeri A, Serjeant GR, Fedorowicz Z (2008) Inhaled nitric oxide for acute chest syndrome in people with sickle cell disease. Cochrane Database Syst Rev 1, CD006957
Mahmmoud YA (2007) Modulation of protein kinase C by curcumin; inhibition and activation switched by calcium ions. Br J Pharmacol 150(2):200–208
Pekoe G, Van Dyke K, Mengoli H et al (1982) Comparison of the effects of antioxidant non-steroidal anti-inflammatory drugs against myeloperoxidase and hypochlorous acid luminol-enhanced chemiluminescence. Agents Actions 12(1–2):232–238
Zrelli H, Matsuoka M, Kitazaki S et al (2011) Hydroxytyrosol reduces intracellular reactive oxygen species levels in vascular endothelial cells by upregulating catalase expression through the AMPK-FOXO3 a pathway. Eur J Pharmacol 660(2–3):275–282
Kinnula VL (2005) Focus on antioxidant enzymes and antioxidant strategies in smoking related airway diseases. Thorax 60:693–700
Shinde A, Ganu J, Naik P (2012) Effect of free radicals & antioxidants on oxidative stress: a review. J Dent Allied Sci 1(2):63–66
Leo MA, Heunks PN, Dekhuijzen R (2000) Respiratory muscle function and free radicals: from cell to COPD. Thorax 55:704–716
Meydani SN, Han SN, Hamer DH (2004) Vitamin E and respiratory infection in the elderly. Ann N Y Acad Sci 1031:214–222
DeMichele SJ et al (2006) A nutritional strategy to improve oxygenation and decrease morbidity in patients who have acute respiratory distress syndrome. Respir Care Clin N Am 12(4):547–566
DeMichele SJ, Wood SM, Wennberg AK (2012) Manipulating antioxidant intake in asthma: a randomized controlled trial. Am J Clin Nutr 96(3):534–543
Stephent T (2008) Pathogenesis of Asthma. Clin Exp Allergy 38(6):872–897
Tonelli AR, Haserodt S, Aytekin M (2013) Nitric oxide deficiency in pulmonary hypertension: Pathobiology and implications for therapy. Pulm Circ 3(1):20–30
Gitto E, Pellegrino S, Gitto P et al (2009) Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin. J Pineal Res 46(2):128–139
Duijvestijn YC, Mourdi N, Smucny J et al (2009) Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease. Cochrane Database Syst Rev 1, CD003124
Nash EF, Stephenson A, Ratjen F et al (2009) Nebulized and oral thiol derivatives for pulmonary disease in cystic fibrosis. Cochrane Database Syst Rev 1, CD007168
Singer P, Shapiro H (2009) Enteral omega-3 in acute respiratory distress syndrome. Curr Opin Clin Nutr Metab Care 12(2):123–128
Bosma KJ, Taneja R, Lewis JF (2010) Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches. Drugs 70(10):1255–1282
Mitev D, Gradeva H, Stoyanova Z et al (2010) Evaluation of thiol compounds and lipid peroxidative products in plasma of patients with COPD. Trakia J Sci 8(suppl 2):306–314
Smit HA (2001) Chronic obstructive pulmonary disease, asthma and protective effects of food intake: from hypothesis to evidence? Respir Res 2:261–264
Tarpey MM, Wink DA, Grisham MB (2004) Methods for detection of reactive metabolites of oxygen and nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol 286(3):R431–R444
Dambrova M, Baumane L, Kalvinsh I et al (2000) Improved method for EPR detection of DEPMPO-superoxide radicals by liquid nitrogen freezing. Biochem Biophys Res Commun 275:895–898
Esterbauer H, Cheeseman KH (1990) Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynoneal. Methods Enzymol 186:407–421
Roberts LJ, Morrow JD (2000) Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radic Biol Med 28:505–513
Aberti A, Bolognini L, Carratelli M et al (1997) Assessing oxidative stress with the D-Romstest. Some mechanistic consideration. Proceedings of the SFRR summer meeting, Padua, pp 82–83
Camera E, Picardo M (2002) Analytical methods to investigate glutathione and related compounds in biological and pathological processes. J Chromatogr B Analyt Technol Biomed Life Sci 781(1–2):181–206
Tsikas D (2005) Methods of quantitative analysis of the nitric oxide metabolites nitrite and nitrate in human biological fluids. Free Radic Res 39(8):797–815
Everett SA, Dennis MF, Tozer GM et al (1995) Nitric oxide in biological fluids: analysis of nitrite and nitrate by high-performance ion chromatography. J Chromatogr A 706(1–2):437–442
Schwedhelm E (2005) Quantification of ADMA: analytical approaches. Vasc Med 10(suppl 1):S89–S95
Siroka R, Trefil L, Rajdl D et al (2007) Asymmetric dimethylarginine—comparison of HPLC and ELISA methods. J Chromatogr B Analyt Technol Biomed Life Sci 850(1–2):586–587
Benzie IFF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of “antioxidant power”: the FRAP assay. Anal Biochem 239:70–76
Said TM, Kattal N, Sharma RK et al (2003) Enhanced chemiluminescence assay vs. colorimetric assay for measurement of the total antioxidant capacity of human seminal plasma. J Androl 24(5):676–680
Skiepko R, Zietkowski Z, Tomasiak MM et al (2006) Exhaled breath condensate in the assessment of airway inflammation. Przegl Lek 63(12):1321–1325
Gokhan M, Kevin W, Robbins R et al (2001) Collection and analysis of exhaled breath condensate in humans. Am J Respir Crit Care Med 164:731–737
Acknowledgement
I gratefully acknowledge the help of my students Vivek Singh Malik, Harsimran Sidhu, and Divya Kapoor for their valuable support extended in preparation of the manuscript.
Conflict of Interest Author declares no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Dhawan, V. (2014). Reactive Oxygen and Nitrogen Species: General Considerations. In: Ganguly, N., Jindal, S., Biswal, S., Barnes, P., Pawankar, R. (eds) Studies on Respiratory Disorders. Oxidative Stress in Applied Basic Research and Clinical Practice. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-0497-6_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0497-6_2
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-0496-9
Online ISBN: 978-1-4939-0497-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)